Invicta Diagnostic's IPO debuted strongly on December 8, listing at ₹100, a 17.65% premium over its issue price of ₹85. The ...

Invicta Diagnostic was trading at Rs 95 on the NSE, a 11.76% premium to the issue price of Rs 85. Invicta Diagnostic's IPO was subscribed 4.05 times. The issue opened for bidding on 1 December 2025 ...

The assay detects aggressive prostate tumors in men on active surveillance for low-risk cancer, potentially helping them ...

A recently disclosed Tri-Century Eye Care data breach stemming from a ransomware attack affects roughly 200,000 individuals.

Shares of Invicta Diagnostic listed at Rs 100 per share on the Emerge platform of the National Stock Exchange (NSE). The Rs 28.12 crore issue had a price band of Rs 80-85 per share.

Invicta Diagnostic is set to debut on the NSE SME platform on December 8, following a successful IPO that raised 28.12 crore.

Explore campus events in Tiruchi, highlighting art competitions, heritage expos, AI workshops, and educational initiatives ...

The Faculty of Medicine, Chulalongkorn University, in collaboration with the Faculty of Engineering, has developed “Deep GI,” ...

Check which GPU is in your PC with just the tools built into Windows itself.

A wearable sensor amplifies subtle everyday sounds to boost mindfulness, helping reduce distraction and offering promise for ...

Natus Medical’s BrainWatch point-of-care EEG solution receives US FDA 510(k) clearance: Middleton, Wisconsin Monday, December 8, 2025, 15:00 Hrs [IST] Natus Medical Incorporated ...

None ...